Cite
Nanomedicine alleviates doxorubicin-induced cardiotoxicity and enhances chemotherapy synergistic chemodynamic therapy.
MLA
He, Yaqian, et al. “Nanomedicine Alleviates Doxorubicin-Induced Cardiotoxicity and Enhances Chemotherapy Synergistic Chemodynamic Therapy.” Journal of Colloid & Interface Science, vol. 663, June 2024, pp. 1064–73. EBSCOhost, https://doi.org/10.1016/j.jcis.2024.03.013.
APA
He, Y., Liu, X., Xu, Z., Gao, J., Luo, Q., He, Y., Zhang, X., Gao, D., & Wang, D. (2024). Nanomedicine alleviates doxorubicin-induced cardiotoxicity and enhances chemotherapy synergistic chemodynamic therapy. Journal of Colloid & Interface Science, 663, 1064–1073. https://doi.org/10.1016/j.jcis.2024.03.013
Chicago
He, Yaqian, Xiaoying Liu, Zichuang Xu, Jiajun Gao, Qingzhi Luo, Yuchu He, Xuwu Zhang, Dawei Gao, and Desong Wang. 2024. “Nanomedicine Alleviates Doxorubicin-Induced Cardiotoxicity and Enhances Chemotherapy Synergistic Chemodynamic Therapy.” Journal of Colloid & Interface Science 663 (June): 1064–73. doi:10.1016/j.jcis.2024.03.013.